09-Oct-15 Many treatments, including Herceptin and Gilead Sciences’ Sovaldi for hepatitis C, are either unavailable or more expensive in China than elsewhere. Aside from the lower price, visitors to Hong Kong from the mainland also prefer to buy their medicine there because they believe it is less likely to be counterfeit. [image: Bloomberg Business]

31-Aug-15 Patients in Hong Kong wait far longer to gain access to innovative medicine than in many other locations because regulations are based on old, rigid protocols. It takes around 18 to 24 months for the authorities to recognise a new drug, while the same medicine can be approved in just 60 days in Singapore. [image: Henry Wong]

13-Aug-15 With a view to further expanding its pan-Asia presence, Singapore's Fullerton Healthcare recently inked a deal to acquire a majority stake in HMMP Limited, a medical network based in Hong Kong. The acquisition will help Fullerton in its mission to transform healthcare standards across Asia, and make it more accessible and affordable, the company said. [image: Fullerton Healthcare]

17-Jul-15 Hong Kong's government will pump HK$1.17 bn (USD150 mn) into the Hospital Authority in the next three years to implement proposals aimed at shortening waiting times and improving funding allocation to three hospital clusters. [image: The Standard]

25-Jun-15 Medication errors cause most "serious untoward events" in Hong Kong's public hospitals, the most frequent being wrong dosage. Such problems caused by doctors' heavy workload and an outdated dispensary system are being addressed by an e-prescription system which is to be installed in 17 hospitals by Dec-18, with up to 30% reduction in medication errors. [image: South Morning China Post_Jonathan Wong]